We have organized this information by conventional discipline. If you aren't finding the information you are looking for, please contact us.
It’s divided into two primary branches:
Often referred to as the "fight or flight" system, it prepares your body to respond to stress or danger by increasing heart rate, dilating airways, and redirecting blood flow to muscles.
Known as the "rest and digest" system, it slows the heart rate, promotes digestion, and supports recovery and repair.
The balance between these two branches is critical for health, resilience, and healing.
It’s divided into two primary branches:
Often referred to as the "fight or flight" system, it prepares your body to respond to stress or danger by increasing heart rate, dilating airways, and redirecting blood flow to muscles.
Known as the "rest and digest" system, it slows the heart rate, promotes digestion, and supports recovery and repair.
The balance between these two branches is critical for health, resilience, and healing.
Thanks to advances in technology, we can now assess the health of the autonomic nervous system using non-invasive tools like Physio PS, a system deployed worldwide and utilized by physicians, clinicians, and researchers.
Physio PS can provide real-time data on how the body’s nervous system responds to stress, movement, and recovery. This data can guide healthcare providers — including, general physicians, cardiologists, neurologist, osteopaths, endocrinologists, physical therapists, chiropractors, and more — to make more informed treatment decisions, especially for patients who aren’t improving with standard care.
With the additional information from P&S Monitoring, more specific and individualized therapy plans may be developed. Some diagnoses maybe either parasympathetically-mediated or sympathetically mediated, yet both mediations lead to the same set of symptoms.
For example, hypertension may be a primary, Sympathetic excess, or may be a Sympathetic excess (SE) secondary to a (primary, co-existing) Parasympathetic excess (PE); both autonomic branches are over-active.
If hypertension is due to a primary SE, standard sympatholytics (e.g., antihypertensives) is indicated.
If hypertension is due to a SE secondary to PE, therapy should first treat the PE, and then if any SE remains, complete the therapy plan with sympatholytics.
Note, this tends to be the more difficult to manage form of hypertension.
To treat PE without co-morbid heart disease, consider low-dose anticholinergic therapy (in the form of very, low-dose antidepressant).
If hypertension is due to a SE secondary to PE, therapy should first treat the PE, and then if any SE remains, complete the therapy plan with sympatholytics. Note, this tends to be the more difficult to manage form of hypertension.
Most chronic diseases involve at least one of 4 autonomic dysfunctions. Classified as high or low Parasympathetic (P), or high or low sympathetic (S); at rest or when challenged. Restoring or establishing P&S balance (i.e., normalizing Sympathovagal Balance (SB) at rest, or returning proper coordination upon challenge) reduces the individual’s morbidity and mortality risk, as well as the number of co-morbidities. Once the P&S nervous systems are properly balanced, both at rest and coordinated upon challenge, any remaining symptoms are due to end-organ effects. These symptoms may now be more aggressively treated.
Physio PS specializes in the development of custom software solutions helping healthcare organizations to predict risk of chronic disease and catastrophic injury by leveraging the Medicare Annual Wellness Visit.
Physio PS provides physicians with a custom complete solution for processing the Medicare Annual Wellness Visit (AWV) for your Medicare Part B and Medicare Advantage patients.
Physio PS is committed to provide healthcare professionals with the opportunity to enhance patient care while contemporaneously increasing practice revenue.
Physio PS Services is designed to operate as the preeminent leader in comprehensive and technologically advanced medical solutions for healthcare professionals across the nation, by providing state-of-the-art, medical technology and services affording their patients transcending preventative care, while increasing practice revenue potential.
At Physio PS, improving healthcare is our focus and passion. Our custom client platform provides the finest technology based on advanced scientific principles, complemented by medical technology support services.
Recognizing technology and medical science is rapidly evolving, ANS monitoring with Physio PS enables our physicians with an innovative approach to address health and wellness challenges across the broad spectrum of healthcare disciplines.
There are numerous reasons for headaches: medication mismanagement, neurologic, cardiologic, etc. P&S Monitoring provides more information to further differentiate. Whether P or S, P&S-mediated headaches are associated with improper brain perfusion (too little or too much, respectively), triggering the neurological effects that underlie headache. P&S Monitoring specifies which and enables more specific therapy. Once P&S balance is established, any remaining symptoms are due to a brain disorder.
There are numerous reasons for tension headaches. Tension tends to indicate high SB or challenge SE.
Like headache, there are many forms of migraine, some Parasympathetically-mediated alike headaches, there are many forms of migraine, some Parasympathetically-mediated and some Sympathetically mediated. Whether P or S, P&S-mediated migraines are associated with improper brain perfusion (too little or too much, respectively), triggering the neurological effects that underlie migraine. P&S Monitoring specifies which and enables more specific therapy. Once P&S balance is established, any remaining symptoms are due to a brain disorder.
ADD/ADHD is characterized by a dynamic (challenge) PE that causes a challenge SE that is responsible for both the attention deficit and the hyperactivity. In essence, the PE induces a form of depression due to PE-induced marginal or poor brain perfusion. The secondary SE causes the “adrenaline storm” that underlies the attention deficit and the hyperactivity. We have had success switching these patients from the standard therapies (characterized by high dose, long-term) to low-dose, short-term anti-cholinergic therapy, and have relieved the disorder within 18 months. Once P&S balance is established, any remaining symptoms are due to a brain disorder.
As a catecholaminergic disorder, the P&S nervous systems are involved. While P&S balance helps to maintain quality of life longer, it does not always help to slow the disease process. P&S Monitoring will identify autonomic neuropathy, including Cardiovascular Autonomic Neuropathy, to help minimize mortality risk.
Depression is characterized by PE, either resting or challenge, or both. All antidepressants are types of anti-cholinergics. The less the BP effect of these medications, the less of a P&S effect. Depression that persists after P&S are balanced, is psychological. P&S imbalance is the physiologic component and is associated marginal or poor brain perfusion. Once P&S balance is established, any remaining symptoms are psychological issues.
From a P&S perspective, Bipolar Disease is a primary PE disorder; therefore, and primary depression disorder. Once the PE is normalized, the SE (secondary to PE) is typically relieved organically, without additional medication. With P&S imbalance, the anxiety phases of Bipolar Disease are cycled when brain perfusion becomes too low, typically after an event that is associated with increased Parasympathetic tone (after large meals, before bedtime, after emotional responses). Once P&S balance is established, any remaining symptoms are psychological issues.
There are two underlying P&S forms: (1) resting high SB (indicating resting SE) as the primary P&S disorder; and (2) challenge PE, causing secondary SE, releasing excess adrenaline causing anxiety secondary to the challenge PE. The latter involves depression. The commonly experienced heart palpitations, in either case, are due to the associated SE, but are typically not life threatening due to SE that is not critical. Once P&S balance is established, any remaining symptoms are psychological issues.
PTSD is associated with what are known as “Quality of Life” (QoL) symptoms: sleep, GI, bladder and bowel dysfunction, lightheadedness upon standing, sex dysfunction, high BP, and depression. The opposing symptoms of depression and high BP help to confirm that PTSD involves both PE and SE; specifically challenge PE, leaving the SE as secondary. While P&S monitoring and guided therapy help to normalize QoL symptoms, it does not directly address the “trigger;” however, it has been found that once the QoL symptoms are normalized, patients are significantly better able to manage the trigger.
Disorders characterized by night-time sleeplessness are associated with SE, and disorders characterized by day-time sleepiness are associated with PE. Once P&S balance is established, any remaining symptoms may be psychological, hormonal, or neurological issues.
MSA and Parkinson’s Disease are nearly identical in the early stages. Treating one with the therapy for the other, accelerates the progression of the one. Since Parkinson’s Disease preserves Sympathetic innervation to the heart, P&S Monitoring differentiates the two earlier, helping to ensure proper therapy planning. Once P&S balance is established, any remaining symptoms are due to the disorder itself.
Idiopathic Peripheral Autonomic Neuropathy is one of the earliest signs of P&S dysfunction, enabling earlier and more aggressive therapy to slow or stay the progression of autonomic neuropathy by establishing and maintaining P&S balance.
CRPS is characterized by pain with both SE and PE. The SE due to the “stress” of pain and the PE due to compromised blood flow (e.g., due to plexus damage) to one or multiple regions of the body.
While P&S balance helps to maintain quality of life longer, it does not always help to slow the disease process. P&S Monitoring will identify autonomic neuropathy, including Cardiovascular Autonomic Neuropathy, to help minimize mortality risk.
Sensory and motor neuropathies are preceded by autonomic neuropathy causing poor circulation inducing or exacerbating the others.
This disease also affects the P&S systems. While P&S balance helps to maintain quality of life longer, it does not always help to slow the disease process. P&S Monitoring will identify autonomic neuropathy, including Cardiovascular Autonomic Neuropathy, to help minimize mortality risk.
In general, Orthostatic dysfunction is associated with alpha-sympathetic (adrenergic) insufficiency (Sympathetic Withdrawal, or SW) causing lower extremity vascular dysfunction upon standing, which causes a drop in BP upon standing (head-up postural change). P&S Monitoring quantitatively specifies SW, helping to differentiate Orthostatic dysfunction, including Orthostatic Intolerance, Orthostatic Hypotension, Orthostatic Hypertension, and Postural Orthostatic Tachycardia Syndrome (POTS), from other causes of dizziness and lightheadedness (including Syncope). Treat the SW to relieve any of the forms of Orthostatic dysfunction. Note, the majority of patients with Orthostatic dysfunction are found to simply be dehydrated. Consider proper daily hydration as the primary recommendation.
In general, Syncope is (beta-) SE with standing (head-up postural change), in other words, a cardiac issue. P&S Monitoring can positively identify Vasovagal Syncope (stand SE with PE), and Neurogenic Syncope (stand SE with an abnormal HR response to stand). Cardiogenic Syncope is a diagnosis by omission. While Neurocardiogenic Syncope is the most commonly diagnosed form, P&S Monitoring helps differentiate the �?neuro’ component from the �?cardio’. Treat PE for Vasovagal syncope. Treat the HR abnormality for Neurogenic. Consider additional cardiac testing, including tilt table, to positively diagnose and treat Cardiogenic Syncope.
POTS and Vasovagal Syncope are difficult to differentiate, even with tilt-table. P&S Monitoring quantitates the Sympathetic response to stand (head-up, postural change), differentiating stand SW (indicating orthostatic dysfunction, including POTS) from stand SE (indicating Syncope). This is more information that enables more individualized therapy planning, including the possibility of both Orthostatic dysfunction and Syncope concurrently.
Chronic Hypotension is characterized by low SB or challenge PE. Once P&S balance is established, any remaining symptoms are cardiovascular issues.
As indicated above there are multiple reasons for lightheadedness and dizziness, including Vestibular dysfunction, especially in geriatrics. Consider both Vestibular testing and P&S Monitoring to fully document and diagnose and determine therapy.
Chronic Fatigue Syndrome is characterized by low SB or challenge PE.
Sleep Disturbances are characterized by Parasympathetic insufficiency followed by SE. Parasympathetic insufficiency underlies the collapse of the soft palate, and then the stress of not breathing while sleeping and then not sleeping causes the SE. Note, sleep apnea therapies (e.g., CPAP) are not direct sympatholytics; therefore, they only relieve the “stress” of not sleeping. They are not sufficient to reduce the SE associated with typical co-morbidities associated with sleep apnea: hypertension, diabetes, obesity, etc. Additional Sympathetic therapies are needed to normalize the mortality and morbidity risk of sleep apnea. P&S Monitoring is often necessary to properly titrate the additional sympatholytic therapy.
Is it a bronchial issue and therefore a Sympathetic dysfunction? The non-steroidal therapies may involve beta-2 adrenergic agonists to broncho-dilate. However, beta-2 adrenergic agonists also affect the heart, increasing HR or BP by causing SE. The associated SE that may be induced, precedes the increase in HR or BP, and P&S Monitoring helps to titrate the asthma therapy to manage the disease without inducing heart diseases via the induced SE. Once P&S balance is established, any remaining symptoms may be pulmonary.
The non-steroidal COPD therapies may involve beta-2 adrenergic agonists to broncho-dilate. However, beta-2 adrenergic agonists also affect the heart, increasing HR or BP by causing SE. The associated SE that may be induced, precedes the increase in HR or BP, and P&S Monitoring helps to titrate the COPD therapy to manage the disease without inducing heart diseases via the induced SE. Once P&S balance is established, any remaining symptoms may be pulmonary.
BP is controlled by Baroreceptor Reflex (BRR), which is controlled by the Sympathetics. Hypertension is typically characterized by SE driving up BRR and then BP. At first, hypertension is due to both an initial decline in resting Parasympathetic activity causing high SB (indicating resting SE) and a (protective) challenge PE causing a secondary challenge SE, then it is due to the continuing effects of SE.
MI causes SE; therefore, post-MI symptoms are due to SE.
The vasculature is uniquely controlled by the Sympathetic nervous system: peripheral vasoconstriction is a function of increased Sympathetic tone increasing BP and shunting blood to the core; peripheral vasodilation is a function of decreased Sympathetic tone decreasing BP and enabling blood flow to the periphery. Angina is a form of Coronary Artery Disease (CAD) and is a function of SE, either due to excess vasoconstriction or due to blockages from atherosclerotic build up.
Atherosclerosis induces SE. It may be induced by SE as SE may involve endothelial dysfunction.
Mitral Valve Prolapse Syndrome is empirically associated with PE, if not a structural cardiac issue.
Cardiomyopathy is characterized by SE, however, its different forms may be induced by other disorders. For example, Hypertrophic Cardiomyopathy is genetically facilitated, with the disorder turning symptomatic if and when Orthostatic dysfunction (associated with α-SW upon standing) or Syncope (associated with α-SE upon standing) is demonstrated.
Cardiac Dysrhythmias are varied and, in part, associated with P&S dysfunction. It is accepted that approximately 80% of atrial dysrhythmias also involve the P&S systems (only 20% are purely cardiogenic). Of the 80% that involve the P&S, approximately 20% are Sympathetically-mediated and 80% are Parasympathetically-mediated. Ventricular dysrhythmias are accepted to also involve the Sympathetics, except repolarizing ventricular dysrhythmias, which are accepted to also involve the Parasympathetics. P&S monitoring helps to specify which branch is involved. Once P&S balance is restored, the remaining symptoms are cardiogenic
CHF is characterized by high SB, indicating a resting SE. Note, resting SE (high SB) precedes even the 3% weight gain indicator and which may be prevented with early intervention, including a temporary increase in diuretic, if the increase in SB is noted (up to 4 days) before the weight gain. This helps to avoid hospitalization.
The P&S systems are intimately associated with the hormonal systems. Hyperthyroidism is characterized by SE (at least in part) causing the over-production of thyroid hormones. Hypothyroidism is characterized by PE (at least in part) shutting down the production of thyroid hormones.
The P&S systems are intimately associated with the hormonal systems. From a P&S perspective, menopausal abnormality is characterized by challenge PE, (at least in part) shutting down the production of estrogen and progesterone. Once P&S balance is established, any remaining symptoms are end-organ issues.
By the time of diagnosis, both forms of Diabetes (types I & II) are characterized by SE: (1) at first due to both an initial decline in resting Parasympathetic activity causing high SB (indicating resting SE) and a (protective) challenge PE causing a secondary challenge SE, (2) then due to the continuing effects of sugar acidosis on the more highly exposed Vagus Nerve which comprises the majority of the Parasympathetic Nervous System. In type II Diabetes, Prediabetes is characterized by challenge PE shutting down (at least in part) the production of insulin. Once P&S balance is established, any remaining symptoms are end-organ issues.
Both are typically characterized by SE: (1) at first due to both an initial decline in resting Parasympathetic activity causing high SB (indicating resting SE) and a (protective) challenge PE causing a secondary challenge SE, (2) then due to the continuing effects of uremia toxicity on the more highly exposed Vagus Nerve which comprises the majority of the Parasympathetic Nervous System. In Hypertensive Renal Disease, resting SE is exacerbated either causing, or caused by, the hypertension.
There are two underlying P&S forms: (1) stress induced, challenge PE (as a protective mechanism), causing secondary SE, releasing cortisol, putting the body into “starvation mode;” and (2) resting low SB (indicating resting PE) keeping metabolism low. Both may involve depression. The former is typically the difficult-to-manage type. The latter is the type that best responds to typical diet programs and is easier to keep off the weight.
The Parasympathetic nervous system provides the immune system its memory and helps to control and coordinate immune responses. Weak P-Activity (including high SB, at rest) promotes immune deficiency.
The gastric system is uniquely controlled by the Parasympathetics. GERD as a result of PE is due to overactive gastric motility. GERD as a result of Parasympathetic insufficiency is due to forms of gastroparesis. Once P&S balance is established, any remaining symptoms may be specifically gastric (end-organ) issues (e.g., smooth muscle, excess gastric secretion, bacterial, etc.).
The gastric system is uniquely controlled by the Parasympathetics. Gastroparesis is (at least in part) a result of Parasympathetic insufficiency. Once P&S balance is established, any remaining symptoms may be specifically gastric (end-organ) issues (e.g., smooth muscle, excess gastric secretion, bacterial, etc.).
The intestinal system is uniquely controlled by the Parasympathetics. IBS with constipation is (at least in part) a result of Parasympathetic insufficiency, causing low motility. IBS with diarrhea is (at least in part) a result of PE, causing excess motility. Once P&S balance is established, any remaining symptoms may be specifically gastric (end-organ) issues (e.g., smooth muscle, excess gastric secretion, bacterial, etc.).
Fibromyalgia is now accepted as an autonomic dysfunction, typically characterized by challenge PE. The associated SE (associated with the amplified pain responses) is typically secondary to the PE and is the main reason why it is difficult to control or respond, seemingly paradoxically, to anti-cholinergic therapy.
Lower body edema is typically associated with SW, causing pooling of blood in the lower vasculature and may result in varicose or spider veins; more generalized edema is associated with PE.
Sex function requires proper coordination between the P&S systems: P for “point”, responsible for erection and vaginal lubrication, and S for “shoot”, responsible for ejaculation and orgasm. Once P&S balance is established, any remaining symptoms may be vascular, psychologic, or hormonal.
This book presents the concepts underlying the measurement of parasympathetic and sympathetic (P&S) activity in the autonomic nervous system and the application of these measurements in the development of therapeutic guidelines for treating dysfunctions in these processes.
It provides an overview of the anatomy, physiology, and biochemistry of the autonomic nervous system; details general clinical applications of P&S monitoring that are independent of specialty or disease; presents the pathophysiology of P&S dysfunction in specific disorders, expected test results, therapeutic options, and expected outcomes; and includes case studies and longitudinal studies that demonstrate the major concepts for the common diseases for which P&S monitoring is recommended.
Clinical Autonomic Dysfunction enables clinicians to improve patient outcomes by identifying and treating clinical problems related to autonomic nervous system disorders
This book establishes and specifies a rigorously scientific and clinically valid basis for non pharmaceutical approaches to many common diseases and disorders found in clinical settings. It includes lifestyle and supplement recommendations for beginning and maintaining autonomic nervous system and mitochondrial health and wellness.
The book is organized around a six-pronged mind-body wellness program and contains a series of clinical applications and frequently asked questions. The physiologic need and clinical benefit and synergism of all six aspects working together are detailed, including the underlying biochemistry, with exhaustive references to statistically significant and clinically relevant studies. The book covers a range of clinical disorders, including anxiety, arrhythmia, atherosclerosis, bipolar disease, dementia, depression, fatigue, fibromyalgia, heart diseases, hypertension, mast cell disorder, migraine, and PTSD.
Clinical Autonomic and Mitochondrial Disorders: Diagnosis, Prevention, and Treatment for Mind-Body Wellness is an essential resource for physicians, residents, fellows, medical students, and researchers in cardiology, primary care, neurology, endocrinology, psychiatry, and integrative and functional medicine. It provides therapy options to the indications and diagnoses published in the book Clinical Autonomic Dysfunction.
There are two aspects of teaching that are required and provided by this book: improved understanding of EDS/HSD and improved understanding of P&S (autonomic) dysfunction and treatment. For example, with the autonomic nervous system, more treatment or therapy is never better. Relief of P&S dysfunction must be low and slow to prevent causing more symptoms from higher doses of medication or polypharmacy. To this end, stress often sets patients back and both providers and patients alike must have proper expectations set for successfully improving patient outcomes (quality of life and productivity).
The book starts with an introduction to and history of the disorder. Chapter II provides a review of the genetics of collagen, the source of the disorders. Chapters III through IX detail the various forms of EDS/HSD and goes into more detail on the more common and more well-known variants of EDS/HSD. Chapter X discusses structural cardiovascular and pulmonary dysfunction associated with EDS/HSD. Chapter XI discusses structural gastrointestinal and urogenital dysfunction associated with EDS/HSD. The book ends with Chapter XII, which details the involvement of the P&S nervous systems and how to treat, which also has general application to other chronic disorders.
This is an ideal guide for rheumatologists and primary care physicians treating patients with Ehlers-Danlos and hypermobility syndromes, and patients and their loved ones in understanding their disease and disorders and the associated treatments and therapies.
The Importance of Parasympathetic Monitoring
As the title may suggest, the use of ANS monitoring may not lead to accurate clinical diagnoses and treatment for many ailments using other technologies available to healthcare professionals. What is missing from this title is the fact that without measuring the Parasympathetic nervous system in total and independently, a correct diagnosis would not be provided. This problem exists in the industry through HRV (Heart Rate Variability) btb-readings, such as btb-Blood Pressure, Pulse Wave Velocity, and more.
OXIDATIVE STRESS: Alpha Lipoic Acid & Coenzyme Q-10
Oxidative stress is a process whereby Free Radicals that are produced by the body cause injury to the tissues themselves; especially one of the most important organelles in the cell, the organelle that produces energy, The Mitochondria. Oxidation is the process of burning, think of fire, or rusting, think of iron.
Coronary heart disease (CHD) is a major health concern, affecting nearly half the middle-aged population and is responsible for nearly one-third of all deaths. Clinicians have responsibilities beyond diagnosing CHD, including risk stratification of patients for major adverse cardiac events (MACE), modifying the risks, and treating the patient. In this first of a two-part review, identifying risk factors is reviewed, including more potential benefits from autonomic testing.
Coronary heart disease (CHD) is a major health concern, affecting nearly half the middle-age population and responsible for nearly one-third of all deaths. Clinicians have several major responsibilities beyond diagnosing CHD, such as risk stratification of patients for major adverse cardiac events (MACE) and treating risks, as well as the patient. This second of a two-part review series discusses treating risk factors, including autonomic dysfunction, and expected outcomes.
Syncope is difficult to definitively diagnose, even with tilt-table testing and beat-to-beat blood pressure measurements, the gold-standard. Both are qualitative, subjective assessments. There are subtypes of syncope associated with autonomic conditions for which tilt-table testing is not useful. Heart rate variability analyses also include too much ambiguity.
To describe early effects of sympathetic (SNS) and parasympathetic nervous system (PSNS) activities measured by heart rate (HR) and respiratory rate variabilities simultaneously with noninvasive hemodynamic patterns in patients with blunt and penetrating trauma.
Reviewing our studies of the ease and importance of Parasympathetic and Sympathetic (P&S) measures in managing cardiovascular patients.
Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk. Specific and sensitive measures of CAN are needed for early identification and treatment to avoid complications, preferably in the preclinical state.
Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk, correlating with the risk of heart disease, silent myocardial ischemia, or sudden cardiac death. Beta-blockers are often prescribed to minimize risk.
The effect of ranolazine (RAN) on cardiac autonomic balance in congestive heart failure (CHF) was studied.
Ranolazine (RAN) reduces cardiac sodium channel 1.5’s late sodium current in congestive heart failure (CHF), reducing myocardial calcium overload, potentially improving left ventricular (LV) function. RAN blocks neuronal sodium channel 1.7, potentially altering parasympathetic and sympathetic (P&S) activity. The effects of RAN on LV ejection fraction (LVEF) and P&S function in CHF were studied.
High sympathetic tone and cardiac autonomic neuropathy (CAN) are associated with major adverse cardiac events (MACE). We have shown ranolazine (RAN) improves autonomic function. RAN was introduced to 51 successive anginal CD patients (RANCD). A control group of 54 successive nonanginal CD patients (NORANCD) continued baseline therapy.
Reviewing our studies of the ease and importance of Parasympathetic and Sympathetic (P&S) measures in managing cardiovascular patients.
Reviewing our studies of the ease and importance of Parasympathetic and Sympathetic (P&S) measures in managing cardiovascular patients.
Continuous monitoring of the patient’s current health status using autonomic biomarkers
Evaluation of treatment efficacy and validation of therapeutic interventions
Comprehensive screening for Cardiac Autonomic Neuropathy (CAN) and Diabetic Autonomic Neuropathy (DAN)
Assessment of key cardiovascular and metabolic indicators, including Metabolic Syndrome, Hypertension, and Heart Failure
Early detection of psychological and stress-related conditions such as burnout, anxiety, and depression
Investigation of autonomic involvement in chronic conditions like Asthma, COPD, Palpitations, Pain syndromes, and Sleep Apnea
Personalized optimization of therapeutic strategies based on individual autonomic profiles
Instant generation of detailed reports featuring qualitative, quantitative, and graphical analysis of ANS balance, cardiovascular function, stress response, physical fitness, and overall health
Integration of real-time data with patient medical history to support clinical decision-making and procedural planning
Streamlined, patient-centered management of complex, multi-symptom presentations
Comprehensive evaluation of current health status, including symptomatology, pharmacological response, and therapeutic impact
Analysis of recovery trajectory to determine the appropriateness and effectiveness of ongoing rehabilitation or treatment
Clinical prioritization to address early indicators of chronic disease development or worsening of existing conditions
Prognostic assessment and evaluation of treatment efficacy to guide long-term care planning
Detection of physiological abnormalities within the cardiovascular and cerebrovascular systems, contributing to a holistic health assessment
Vascular health analysis, including arterial elasticity, peripheral circulation efficiency, and identification of organic or functional vascular impairments
Predictive insight into the development and progression of Arteriosclerosis, Obesity, Hypertension, Hyperlipidemia, and Diabetes
Serves as a reliable physiological health indicator—acting as an internal "health barometer" for preventive and diagnostic purposes
Physio PS specializes in the development of custom software solutions to help healthcare organizations to predict the risk of chronic disease and catastrophic injury by leveraging the Medicare Annual Wellness Visit.
Physio PS provides physicians with a complete, custom solution for processing the Medicare Annual Wellness Visit (AWV) for your Medicare Part B and Medicare Advantage patients.
Physio PS is committed to providing healthcare professionals with the opportunity to enhance patient care while at the same time increasing practice revenue.
Physio PS is designed to operate as the preeminent leader in comprehensive and technologically advanced medical solutions for healthcare professionals across the nation by providing state-of-the-art medical technology and services, affording their patients exceptional preventative care while increasing practice revenue potential.
At Physio PS, improving healthcare is our focus and passion. Our custom client platform provides the finest technology based on advanced scientific principles complemented by medical technology support services.
"Physio PS has been a gamechanger in uncovering the hidden autonomic dysfunctions that often underlie chronic fatigue, persistent pain, anxiety symptoms, and delayed recovery after whiplash and concussion. It’s given us answers when nothing else could — and a clear path to true healing."
"As a VA Electrophysiologist, I’ve used ANSAR’s Parasympathetic and Sympathetic Monitoring for years with outstanding results. It delivers diagnostic insights no other tool can provide. One case—a Navy SEAL suffering from severe dizziness and disability—was accurately diagnosed and effectively treated using ANSAR technology, after traditional tests failed. The patient regained his health, quality of life, and independence. This tool is a game-changer for patient care and healthcare efficiency."
"I cannot say enough good things about Physio PS! This technology has done so much for me. I used to have terrible anxiety storms that would cause me to have high fevers. With this simple test, my doctor was able to find the root cause of my symptoms and prescribe a very low-dose medicine for about nine months to correct the primary problem. I have not had a high fever in four years!"
Copyright 2025. Physio PS, Inc.. All Rights Reserved.
The material and information provided by Physio PS is for general information purposes only. You should not rely upon this material or information for basis of making healthcare, treatment, or diagnosis decisions. While Physio PS strives to provide the most correct and up-to-date information and data, Physio PS makes no representations or warranties of any kind, expressed or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the information, products, services, or related graphics contained. Any reliance placed on such material is therefore strictly at your own risk. Reporting Information is supplied under license by NCRC LLC. * ‘RFa’ is known to be a measure of Parasympathetic activity and ‘LFa’ is known to be a measure of Sympathetic activity, based on reference: Colombo J, Arora RR, DePace NL, Vinik AI, Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY; 2014.
Facebook
Instagram
X
LinkedIn
Youtube